Thu.Jul 20, 2023

article thumbnail

Three things to know from the latest Patient Experience Survey

PhRMA

Most insured Americans believe insurance should provide affordable access to health care (93%), but only a third (34%) say it does, according to the fourth installment of the Patient Experience Survey (PES). The survey — based on interviews with 5,000 Americans — explores this disconnect, detailing the challenges insured Americans face affording care and how practices by health insurers and middlemen put patient lifelines to access at risk.

Insurance 133
article thumbnail

What You Need to Know About the Albuterol Shortage

Drug Topics

The FDA is working quickly to address shortages of the form used in nebulizers.

FDA 187
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Study Shows Combining Telehealth With In-Office Visits for Prenatal Care Performs Adequately Compared With In-Office Only

Pharmacy Times

Not only is a combination of in-office visits and telemedicine an effective model of prenatal care, but it can be an alternative to those who face access barriers.

123
123
article thumbnail

Do’s And Don’ts: Social Media Tips for Pharmacists

Drug Topics

Social media marketing is a powerful tool that pharmacists can use.

187
187
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

DIR Fee Reform Will Have Repercussions in 2024, But Pharmacists Can Prepare

Pharmacy Times

Managing cost savings can soften the blow of direct and indirect remuneration fee reform that will impact pharmacists during the first half of 2024.

123
123
article thumbnail

How New Ideas in Technology Are Changing the Pharmacy Industry

Drug Topics

Drug Topics was recently joined by Kevin Smith, PharmD from Prescyptive Health to talk about how the landscape of pharmacy changing, how AI and technology are part of that change, and what can be done to repair a broken system.

98

More Trending

article thumbnail

Number One No Longer

Drug Topics

Issues within chain pharmacies have made the profession less attractive for new graduates.

144
144
article thumbnail

Smartwatches Show Promise Recording Sleep Times for Those With Sleep Disorders

Pharmacy Times

A smartwatch may be able to replace a sleep diary to evaluate falling asleep and waking times for those with insomnia.

123
123
article thumbnail

Pharmacists Play Key Role in Managing Diabetic Eye Disease

Drug Topics

Patients may not experience any early symptoms, making screening especially important.

144
144
article thumbnail

Novo Nordisk, Eli Lilly and Boehringer Ingelheim back bill to bring obesity drug coverage to Medicare

Fierce Pharma

Despite the widespread hype surrounding new and powerful obesity medicines, the drugs are still out of reach for many Americans who could benefit. | Despite the widespread hype surrounding new and powerful obesity medicines, the drugs are still out of reach for many Americans who could benefit. A group of lawmakers is working to change that.

98
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

These factors could lead ACA plan premiums to rise next year: report

Fierce Healthcare

As the industry gears up for open enrollment to begin this fall, a new report offers a look into the major factors that could impact premium changes in the individual and small group markets. | As the industry gears up for open enrollment to begin this fall, a new report offers a look into the major factors that could impact premium changes in the individual and small group markets.

98
article thumbnail

STAT+: Damages from tornado at Pfizer plant could compound challenges of drug shortages

STAT

The tornado that struck parts of North Carolina on Wednesday not only damaged the immediate area, but could soon make it much harder for countless people across the U.S. and around the world to obtain needed medicines the next time they visit a hospital. Among the damaged buildings was a Pfizer plant in Rocky Mountain, N.C. that produces nearly 30% of all sterile injectable medicines that the company sells to U.S. hospitals.

article thumbnail

OIG raises concern about prior authorization denials in Medicaid managed care

Fierce Healthcare

The Office of Inspector General (OIG) is urging the feds and states to take on greater oversight of prior authorization denials in Medicaid managed care. | The Office of Inspector General is urging the feds and states to take on greater oversight of prior authorization denials in Medicaid managed care.

98
article thumbnail

Sandoz doubles down on biosimilars with $90M Slovenia site where it plans to hire 200

Fierce Pharma

Sandoz is doubling down on its commitment to Slovenia in its globe-trotting biosimilar growth quest. | Sandoz is doubling down on its commitment to Slovenia in its globe-trotting biosimilar growth quest. Its latest move follows a separate $400 million pledge to build a plant in the country.

98
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

CMS gives California, Kentucky the OK to offer mobile crisis intervention teams for Medicaid

Fierce Healthcare

The Centers for Medicare & Medicaid Services (CMS) has approved proposals from California and Kentucky for community-based mobile crisis intervention teams to provide Medicaid crisis services.< | Medicaid crisis service will be offered to residents in California and Kentucky under the federal American Rescue Plan, joining four other states.

98
article thumbnail

Fierce Pharma Asia—Eisai's subcutaneous Leqembi study; Astellas' IRA lawsuit; and GSK's Taiwan recall

Fierce Pharma

After a recent study of Eisai's subcutaneous Leqembi formulation, the company is touting its "promising" results. | Eisai showed off "promising" results from a modeling and bioavailability study of its subcutaneous Leqembi formulation. Astellas joined the growing list of drugmakers taking on the Inflation Reduction Act with legal action.

98
article thumbnail

STAT+: Extensive review finds private equity owners jack up the cost of medical care

STAT

Private equity firms are rapidly buying their way into the U.S. health care system, and as they do, new research finds they tend to increase costs and may also harm quality. A new BMJ systematic review rounded up 55 studies on the effects of private equity buyouts in health care globally to flesh out an overarching conclusion. The team of researchers found that private equity ownership generally means higher costs for patients, insurance companies, and government programs.

article thumbnail

Amount of postpartum care an immigrant receives depends on where she lives: study

Fierce Healthcare

The healthcare challenges awaiting women who’ve given birth can sometimes be more problematic than those they faced during pregnancy and labor. | Recent and undocumented immigrants face barriers to postpartum care that could turn treatable conditions into serious health risks, according to a JAMA Network study.

96
article thumbnail

Critics and defenders weigh in on Stanford president’s resignation after research investigation

STAT

After Stanford University president and prominent neuroscientist Marc Tessier-Lavigne announced he would resign following an investigation into his research, the scientific community did what it always does with new results: engage in a robust internal debate, marked by a variety of opinions. For some, the investigation , which found Tessier-Lavigne failed to “decisively and forthrightly” correct past papers that contained data manipulation, was a positive example of scientific acc

98
article thumbnail

Intranasal CGRP Antagonist Is Approved for the Treatment of Acute Migraines

Drug Topics

Zavegepant joins other CGRP antagonists as an option for individuals experiencing migraine.

98
article thumbnail

BridgeBio’s big week, Lilly’s Alzheimer’s data, & succession at Stanford

STAT

What can Homer teach us about biotech? Has Big Science gotten too big? And what’s the future of treating Alzheimer’s disease? We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Neil Kumar, CEO of BridgeBio, joins us to talk about how his small company came to develop what could be a big drug — and why classical Greek literature remains relevant.

93
article thumbnail

Total Pharmacy Solutions Summit: Integrated Technology Helps Community Pharmacies Improve Health Outcomes

Drug Topics

Technology can bolster and optimize independent pharmacies’ delivery of clinical services.

article thumbnail

A new deal aims to ramp up use of AI in rehab care decisions

STAT

You’re reading the web edition of STAT Health Tech, our guide to how tech is transforming the life sciences.  Sign up to get this newsletter  delivered in your inbox every Tuesday and Thursday.

91
article thumbnail

J&J's Darzalex stays on its upward trajectory as company adds $1B to annual sales projection

Fierce Pharma

With another quarter of strong sales from multiple myeloma drug Darzalex, Johnson & Johnson has boosted its revenue guidance for 2023.

96
article thumbnail

Walmart adds program for government assistance recipients to subscription service

Drug Store News

Walmart+ Assist is a program that offers customers on government assistance 50% off a monthly or annual Walmart+ paid membership plan.

97
article thumbnail

A leading CRO’s chief exec on why a ‘brave new world’ of clinical research is here

PharmaVoice

Peter Benton, co-CEO of Worldwide Clinical Trials, explains how the rise of the mid-sized pharma company has changed drug R&D.

98
article thumbnail

Strategies for a Demanding Market: Attract Top Technicians With Financial, Career Incentives

Drug Topics

Employers must make changes in order to hire and retain high-quality talent.

98
article thumbnail

Pfizer's massive North Carolina plant heavily damaged by tornado, prompting new US drug supply fears

Fierce Pharma

One of the world’s largest sterile injectables plants has landed in the path of a devastating act of nature. | One of the world’s largest sterile injectables plants has landed in the path of a devastating act of nature. Wednesday, Pfizer said its manufacturing facility in Rocky Mount, North Carolina, suffered damage from a tornado. All of the company's employees are safe and accounted for.

76
article thumbnail

Text Message Programs in Pharmacy: Could They be Doing More?

Drug Topics

Most pharmacies are now utilizing text message programs for their customers. How can they be fully utilized, and what is the next step?

76
article thumbnail

Opinion: I introduced the ADA 35 years ago. Now Congress needs to act to ban a practice that devalues disabled lives

STAT

Thirty-five years ago, I was proud to introduce the Americans with Disabilities Act in the House of Representatives, because I know firsthand what it is like to be devalued due to a disability — by society, potential employers, even my parents and my church. My epilepsy came with the added stigma of old Catholic doctrine that I must be possessed.

75
article thumbnail

John Ruane named president of Giant

Drug Store News

Ahold Delhaize USA has revealed the appointment of John Ruane as president of Giant. He had become interim president following the departure of Nick Bertram in September 2022.

75
article thumbnail

A Q&A with Gavi’s Seth Berkley on vaccines, Covid, and challenges ahead

STAT

Seth Berkley, the soon-to-be former CEO of Gavi, the Vaccine Alliance, apologized for being a few minutes late jumping on a Zoom call. Berkley — one of the highest-profile proponents of vaccination on the planet — was under a denial-of-service attack. It was not his first, likely the handiwork of people who object to Gavi’s efforts to help lower-income countries purchase vaccines at affordable prices.

article thumbnail

After winning full FDA nod for Leqembi, Eisai touts 'promising' study on subcutaneous version

Fierce Pharma

Right on the heels of an FDA approval for the closely watched Alzheimer's disease drug Leqembi in an intravenous dose, Eisai is touting "promising" findings that the company says support the case f | Right on the heels of an FDA approval for the closely watched Alzheimer's disease drug Leqembi in an intravenous dose, Eisai is touting "promising" findings that the company says support the case for a subcutaneous version.

FDA 75
article thumbnail

TPG strikes $1.4B deal to buy EHR, practice management software firm Nextech

Fierce Healthcare

Asset management firm TPG is buying healthcare IT company Nextech from Thomas H. Lee Partners for $1.4 billion, the company announced Wednesday. | Asset management firm TPG is buying healthcare IT company Nextech from Thomas H. Lee Partners for $1.4 billion, the company announced Wednesday.

74